JeanMarie Guenot, The President of Amphivena Therapeutics

Jeanmarie Guenot has a portfolio with twenty years of experience. She has been in the field of the biotechnology industry and pharmaceutical acquiring vast experience. Guenot got her Ph.D. from the University of California. She also attended the University of Pennsylvania where she earned her MBA from The Wharton School. Her experience is in many areas. She has worked in private sectors and public areas. She has helped in Venture Capital, Corporate, Project Management and Alliance Management and Pharmaceutical R & D.

She has worked in various positions before giving her first class services to Amphivena Therapeutics. Guenot has offered her advisory services to Hoffmann-La Roche in Basel and Shanghai. She is also a businesswoman, and she is the founder a startup company called SKS Ocular. She worked with the company in many areas such as release and delivery of ocular drugs, macular degeneration, glaucoma and inflammation of ocular. She is a winner of several awards and recognitions on guenotllc.com. For example, she was awarded the Bio Network Award for innovation in 2005.

At the moment she made a decision to offer services to Amphivena Therapeutics. Jeanmarie Guenot is also the president of the firm. It is a company that has succeeded for now. It has specialized in researching and coming up with ways to combat blood cancer. The firm began in 2013, and its headquarters are in San Francisco California. The business was established to ensure that patients can have healthy lives since cancer is a disease that is life-threatening. Therapies are contacted so as to do away with the blood cancers.

Through the services, the immune system of the patient can destroy the cells that are cancerous. The organization has achieved a lot since it began. It is because of excellent leadership of passionate and strong willed lady that the company has helped many cancer patients who would have died if they were not given the proper attention. The company also made a deal with Janssen Biotech, and it became successful on amphivena.com. Janssen Biotech was pleased with the achievements and released payments to the enterprise. With the leadership of JeanMarie Guenot, there is no doubt that the corporation will continue excelling.

Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

Leave a Reply

Your email address will not be published. Required fields are marked *